Related Experiment Videos
Prostaglandin and complement interaction in clinical acute respiratory failure
Archives of Surgery (Chicago, Ill. : 1960)
|March 1, 1986
Summary
This study found elevated complement component C3a and granulocyte aggregation in acute respiratory failure (ARDS) patients. These markers suggest systemic complement activation, potentially involving prostaglandins and granulocytes in ARDS pathogenesis.
Area of Science:
- Pulmonary Medicine
- Immunology
- Biochemistry
Background:
- Acute Respiratory Distress Syndrome (ARDS) is a severe condition with high mortality.
- The roles of circulating prostaglandins and complement activation in ARDS are not fully understood.
Purpose of the Study:
- To investigate the interaction between plasma levels of prostaglandins and activated complement in patients at risk for ARDS.
- To identify biomarkers associated with ARDS development and mortality.
Main Methods:
- Prospective study of 50 patients at risk for ARDS, followed for 10 days.
- Daily measurements of arterial blood gases, complement components (C3a, C5a), prostaglandins (TxB2, PGI), and granulocyte aggregation (GA).
Main Results:
- 17 patients (34%) developed ARDS.
- ARDS patients showed significantly increased plasma C3a and GA compared to non-ARDS patients.
- Plasma C5a, TxB2, and PGI levels did not differ significantly between groups.
- No measured variable correlated significantly with mortality.
- Regression analysis indicated correlations between GA, TxB2, PGI, and arterial oxygenation.
Conclusions:
- Elevated plasma C3a and GA in ARDS suggest systemic complement activation.
- Interactions between prostaglandins, complement, and granulocyte aggregation may play a role in ARDS pathophysiology.